IRIS
DI MARIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.868
AS - Asia 24.859
EU - Europa 14.651
SA - Sud America 3.794
AF - Africa 1.382
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 54
Totale 72.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.153
SG - Singapore 10.403
CN - Cina 8.236
IE - Irlanda 3.628
SE - Svezia 3.303
BR - Brasile 3.031
HK - Hong Kong 1.829
VN - Vietnam 1.494
TR - Turchia 1.490
DE - Germania 1.339
UA - Ucraina 1.241
FI - Finlandia 1.199
ZA - Sudafrica 969
IT - Italia 967
NL - Olanda 942
RU - Federazione Russa 556
GB - Regno Unito 498
CA - Canada 460
AR - Argentina 296
IN - India 295
FR - Francia 196
BD - Bangladesh 178
CI - Costa d'Avorio 177
BE - Belgio 149
MX - Messico 149
IQ - Iraq 136
EC - Ecuador 126
PL - Polonia 115
ID - Indonesia 108
AT - Austria 105
JP - Giappone 104
CO - Colombia 82
ES - Italia 73
UZ - Uzbekistan 62
VE - Venezuela 62
PK - Pakistan 61
EU - Europa 59
PY - Paraguay 59
LT - Lituania 58
KR - Corea 57
MA - Marocco 56
CL - Cile 51
AU - Australia 50
IR - Iran 49
RO - Romania 47
EG - Egitto 45
CZ - Repubblica Ceca 39
KE - Kenya 39
AE - Emirati Arabi Uniti 37
SA - Arabia Saudita 36
IL - Israele 33
PE - Perù 32
HU - Ungheria 29
UY - Uruguay 28
AZ - Azerbaigian 27
BG - Bulgaria 27
TN - Tunisia 27
BO - Bolivia 23
DZ - Algeria 23
JO - Giordania 22
CR - Costa Rica 20
PA - Panama 19
MY - Malesia 18
KG - Kirghizistan 17
DO - Repubblica Dominicana 16
PH - Filippine 16
KZ - Kazakistan 15
LB - Libano 15
AL - Albania 14
JM - Giamaica 14
NP - Nepal 13
PT - Portogallo 13
RS - Serbia 13
SK - Slovacchia (Repubblica Slovacca) 13
TW - Taiwan 13
CH - Svizzera 11
HR - Croazia 11
BY - Bielorussia 10
OM - Oman 10
BH - Bahrain 9
LV - Lettonia 9
SN - Senegal 9
GE - Georgia 8
HN - Honduras 8
LK - Sri Lanka 8
MD - Moldavia 8
TT - Trinidad e Tobago 8
AM - Armenia 7
EE - Estonia 7
ET - Etiopia 7
GR - Grecia 7
KH - Cambogia 7
PS - Palestinian Territory 7
TH - Thailandia 7
BN - Brunei Darussalam 5
KW - Kuwait 5
LU - Lussemburgo 5
NO - Norvegia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CG - Congo 4
Totale 72.581
Salva come PNG Salva come JPEG
Città #
Singapore 4.895
Chandler 4.808
Dublin 3.618
Ashburn 3.081
Santa Clara 2.152
Hong Kong 1.813
Beijing 1.777
Dearborn 1.619
Nanjing 1.316
Izmir 1.236
Jacksonville 1.222
Boardman 1.171
Dallas 997
Johannesburg 919
Princeton 831
Ho Chi Minh City 618
New York 587
Shanghai 512
Wilmington 464
San Mateo 446
Los Angeles 440
Munich 434
Moscow 431
Helsinki 417
Ann Arbor 399
Shenyang 379
Nanchang 360
Columbus 323
Hanoi 319
Hebei 297
Toronto 285
São Paulo 266
Tianjin 248
Kunming 243
Jinan 227
Changsha 225
Hefei 220
Jiaxing 203
Kocaeli 174
Parma 173
Abidjan 170
Buffalo 160
Guangzhou 141
San Jose 141
The Dalles 133
Brussels 131
Norwalk 131
Seattle 124
Hangzhou 120
Chicago 115
Turku 106
Zhengzhou 103
Frankfurt am Main 96
Fremont 92
London 91
Tokyo 90
Pune 89
Brooklyn 83
Rio de Janeiro 83
Warsaw 83
Council Bluffs 74
Vienna 74
Des Moines 73
Bremen 70
Houston 70
Montreal 70
Denver 69
Stockholm 69
Ningbo 68
Belo Horizonte 66
Milan 61
Nuremberg 59
Atlanta 56
Phoenix 56
Boston 55
Porto Alegre 54
Haiphong 53
Baghdad 52
Biên Hòa 51
Chennai 51
Tashkent 51
Woodbridge 51
San Francisco 50
Curitiba 47
Washington 47
Da Nang 45
Orem 45
Brasília 42
Quito 42
Campinas 41
Poplar 41
Rome 39
Seoul 39
Grafing 38
Dhaka 37
Taizhou 37
Bologna 35
Nairobi 35
Wuhan 35
Edinburgh 34
Totale 44.509
Salva come PNG Salva come JPEG
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 257
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 198
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 187
Coffee intake and gastroesophageal reflux: Relationship with clinical, endoscopic and functional features 180
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 174
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 167
Approach to gastroenterological diseases in primary care 159
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 156
Burning Mouth Syndrome Etiology: A Narrative Review 154
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 153
Thyroid and celiac disease in pediatric age: a literature review 150
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 147
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 147
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 147
Is it possible to withdrawal PPI’s therapy in GERD patients? A prospective study on 216 patients using HYCHSA 146
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 146
Long-term treatment for gastric and duodenal ulcer 144
Advanced gastric cancer: the value of surgery 144
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 140
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 140
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 140
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 138
Clinical markers of slow healing and relapsing gastric ulcer 138
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 138
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 137
Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance 135
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 134
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 134
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 134
Acid-related disorders in the elderly 133
How and when investigating and treating Helicobacter pylori infection in children 133
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 132
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 132
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 132
Conservative treatment of acute appendicitis 132
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 131
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 131
Individualized treatment of duodenal ulcer disease. A pilot study 131
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 131
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 130
Association of keratin 8 gene mutation with chronic pancreatitis 129
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 129
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 129
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 129
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 129
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 128
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 128
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 128
Serum pepsinogen II for early assessment of success of H. pylori eradication 128
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 128
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 127
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 127
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study 127
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 127
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 126
Gastric and duodenal ulcer in the same patient 126
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 126
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 125
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 125
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 125
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 125
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy 125
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 125
THE SLEEPING REMNANT 124
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 123
H2-blockers in the treatment of ulcer disease in the elderly 123
A non-invasive method for the diagnosis of upper GI diseases 123
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 123
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 123
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. 122
[Ca 19-9 in the diagnosis of pancreatic carcinoma] 122
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 122
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 122
Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department? 122
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 121
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 121
Epidemiology and risk factors for diverticular disease 121
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 121
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 120
P.154 CONNECTIONS BETWEEN GENETICS AND CLINICAL DATA: ROLE OF MCP-1, CFTR, AND SPINK-1 IN THE SETTING OF ACUTE, ACUTE RECURRENT, AND CHRONIC PANCREATITIS 120
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study) 120
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 120
Microsatellite instability in colorectal cancer 120
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 120
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 120
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 119
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 119
Does chronic hypercalcemia influence serum pepsinogens levels? 119
Compliance with therapy for ulcer disease: clinical experience and review of the literature 119
Epidemiology and risk factors of pancreatic cancer 119
Azithromycin for the cure of Helicobacter pylori infection 119
W1235 Efficacy of 5-ASA in the Treatment of Colonic Diverticular Disease: A Systematic Review 118
P.01.13: Gastrin-17 as a Non-Invasive Marker for Gerd: A Prospective Study on Sample of 777 Consecutive Patients 118
Gastro panel® for detection of atrophic gastritis: The “Parma model” 118
[Alcohol-dependent mast cell activation in ulcer] 118
Helicobacter pylori, transmission routes and recurrence of infection: state of the art 118
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 118
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 118
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 118
Abnormal levels of pepsinogen I and gastrin 17 in a case of Ménétrier Disease 118
Totale 13.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 278.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 278.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.412 0 0 0 0 0 49 260 11 431 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202314.711 1.540 1.337 984 1.304 1.153 1.798 103 1.127 4.622 60 555 128
2023/20244.820 251 577 136 136 414 1.364 214 351 145 282 398 552
2024/202516.639 347 988 1.140 853 1.997 1.879 504 660 2.511 1.562 1.396 2.802
2025/202618.513 3.017 3.075 3.337 2.646 4.984 1.454 0 0 0 0 0 0
Totale 73.403